Lin Health just locked in an $11M Series A, and it lands like a long overdue wake up call to a healthcare system that keeps treating chronic pain like a mystery novel missing the last chapter. When a condition costs the U.S. $635B a year yet gets patched with opioids, waitlists, and guesswork, you know the market is begging for someone to stop improvising and start engineering. Lin Health stepped in with a name that practically writes its own metaphor. They build the line between pain science and real recovery, threading neuroscience, coaching, and clinical rigor into a model that finally respects how the brain actually works.
Credit goes to Co Founder and CEO Yehuda Kogan and Co Founder Dr. Abigail Hirsch, PhD for refusing to treat 1 in 5 Americans like statistical background noise. They built a virtual chronic pain recovery clinic powered by an AI-based care platform tuned to the nervous system instead of the old structural rabbit holes. Patients get physician oversight, high frequency coaching, and behavioral protocols like PRT, CBT, EAET, and somatic tracking. This is the opposite of spray and pray digital health. This is deliberate, pattern-based care that thousands of patients have already experienced across a national footprint anchored by medical groups in Denver and Irving.
Proofpoint Capital led the round, and adding Dan Goldsmith to the board is the kind of operator move that signals a team preparing for real scale. Osage Venture Partners and NewHealth Ventures stepped in, while aMoon, Mayo Clinic, Saban Ventures, Shoni Health Ventures, and Viola Ventures reaffirmed their stake like they have been watching the data build toward this moment. You do not get returning investors like that unless the product is working at the ground level, where pain either improves or it does not. Lin Health has been showing improvement rates most clinics would trade a decade of strategy decks to match.
Coverage now reaches 60M insured Americans, a jump from 24M the year prior. That kind of expansion does not happen unless payers see cost curves actually changing. Health systems are lining up for integrations, and Mayo Clinic’s collaborations show what happens when traditional care finally gets a scalable partner that can touch patients multiple times a week without collapsing under overhead.
This $11M fuels product innovation, deeper system partnerships, and a push to cement chronic pain recovery as a first line option instead of a last resort. If the industry has been searching for a signal in the noise, Lin Health is starting to sound like the frequency everyone else will eventually have to tune to.
Startups Startup Funding Venture Capital Series A AI Healthcare Health Tech Data Data Driven Technology Innovation Tech Ecosystem Startup Ecosystem
